Pharmacological Management of Obese Patients with Type 2 Diabetes amid COVID-19 Pandemic

Obes Surg. 2021 Jan;31(1):413-414. doi: 10.1007/s11695-020-04799-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetes Mellitus, Type 2* / epidemiology
  • Humans
  • Obesity / complications
  • Obesity / epidemiology
  • Obesity, Morbid* / surgery
  • Pandemics
  • SARS-CoV-2